Spots Global Cancer Trial Database for verruca vulgaris
Every month we try and update this database with for verruca vulgaris cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts | NCT01286441 | Common Warts | 10% EISO Placebo 20% EISO 30% EISO | 18 Years - | ViroXis Corporation | |
Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy | NCT01609530 | Verruca Vulgari... | Liquid Nitrogen... Pulsed 1064nm N... | 18 Years - 75 Years | Saint Joseph Mercy Health System | |
Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study | NCT04793529 | Verruca Vulgari... Involucrin | Cholecalciferol | 18 Years - 45 Years | Benha University | |
Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts | NCT02151630 | Plantar Wart | Pyruvic acid Salicylic Acid | 12 Years - | Isfahan University of Medical Sciences | |
Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts | NCT02151630 | Plantar Wart | Pyruvic acid Salicylic Acid | 12 Years - | Isfahan University of Medical Sciences | |
Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts) | NCT02640820 | Common Warts HPV (Human Papi... Periungual Wart... Plantar Warts | Sensitizing DPC... Treatment DPCP ... | 18 Years - 65 Years | RXi Pharmaceuticals, Corp. | |
Cantharidin and Occlusion in Verruca Epithelium | NCT03487549 | Common Wart Warts Hand Warts Papillomavirus ... DNA Virus Infec... Skin Diseases, ... Skin Diseases, ... Skin Diseases Virus Diseases Tumor Virus Inf... Verruca Vulgari... Verruca | VP-102 Canthari... VP-102 Canthari... | 2 Years - | Verrica Pharmaceuticals Inc. | |
Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study | NCT04793529 | Verruca Vulgari... Involucrin | Cholecalciferol | 18 Years - 45 Years | Benha University | |
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts | NCT05799157 | Verruca Vulgari... Warts Common Wart | VDMN-21 Patch L... VDMN-21 Patch H... Vehicle Patch | 12 Years - 65 Years | Veradermics, Inc. | |
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) | NCT02393417 | Warts | CANDIN Placebo | 18 Years - 65 Years | Nielsen BioSciences, Inc. | |
Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study | NCT04793529 | Verruca Vulgari... Involucrin | Cholecalciferol | 18 Years - 45 Years | Benha University | |
Cantharidin and Occlusion in Verruca Epithelium | NCT03487549 | Common Wart Warts Hand Warts Papillomavirus ... DNA Virus Infec... Skin Diseases, ... Skin Diseases, ... Skin Diseases Virus Diseases Tumor Virus Inf... Verruca Vulgari... Verruca | VP-102 Canthari... VP-102 Canthari... | 2 Years - | Verrica Pharmaceuticals Inc. | |
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts | NCT05799157 | Verruca Vulgari... Warts Common Wart | VDMN-21 Patch L... VDMN-21 Patch H... Vehicle Patch | 12 Years - 65 Years | Veradermics, Inc. |